PMC5925971_01
Biopsy with convex probe Pentax.
gr1.jpg
PMC5925971_01_gr1.jpg
fig1
We present a case of a 64 year old female diagnosed with convex probe endobronchial ultrasound (EBUS) from lymphnode number 7 with adenocarcinoma almost a year ago (right lung mass) (Fig. 1).
PET-CT upon diagnosis.
gr2.jpg
PMC5925971_01_gr2.jpg
fig2
The patient was stage IIIB upon diagnosis and upon restaging mediastinum lymph nodes remained still active >6SUV although the primary lesion diameter had decreased from 6 cm to 3 cm (Fig. 2.).
PET-CT after 4 months.
gr3.jpg
PMC5925971_01_gr3.jpg
fig3
After 4 months of treatment break immunotherapy was initiated 180 mg every 15 days, since a new lesion was observed in the left lower lobe of 2 cm (Fig. 3).
Upper hand surface.
gr4.jpg
PMC5925971_01_gr4.jpg
fig4
Three days after the second nivolumab administration the patient started to have severe clinical findings of peeling in both upper and lower limbs (Fig. 4, Fig. 5).